What is the impact of microvascular complications of diabetes on severe COVID-19?
Microvasc Res
; 140: 104310, 2022 03.
Article
em En
| MEDLINE
| ID: mdl-34979154
ABSTRACT
Evidence suggests severe coronavirus disease-19 (COVID-19) infection is characterised by pulmonary and systemic microvasculature dysfunction, specifically, acute endothelial injury, hypercoagulation and increased capillary permeability. Diabetes, which is also characterised by vascular injury in itself, confers an increased risk of adverse COVID-19 outcomes. It has been suggested that pre-existing endothelial dysfunction and microvascular disease in diabetes will exacerbate the vascular insults associated with COVID-19 and thus lead to increased severity of COVID-19 infection. In this article, we evaluate the current evidence exploring the impact of microvascular complications, in the form of diabetic retinopathy and nephropathy, in individuals with COVID-19 and diabetes. Future insights gained from exploring the microvascular injury patterns and clinical outcomes may come to influence care delivery algorithms for either of these conditions.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Endotélio Vascular
/
Trombofilia
/
Angiopatias Diabéticas
/
Pandemias
/
SARS-CoV-2
/
COVID-19
/
Microcirculação
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
En
Revista:
Microvasc Res
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Reino Unido